• Verily Announces Partnership With Temasek

    Bio-IT World Brief | Verily Life Sciences today announced that it will partner with Temasek as it advances plans to commercialize healthcare solutions for global markets with its development partners.

    Jan 27, 2017

  • Johnson & Johnson Innovation, Illumina, QIAGEN, And More: News From January 2017

    Bio-IT World Brief | News, products, and partnerships from around the bio-IT community including news from Johnson & Johnson Innovation, Illumina, QIAGEN, and more.

    Jan 26, 2017

  • Merck & Co. Opens Cambridge Exploratory Science Center, Plans To Hire 30 More Employees

    BioSpace.com | The end of 2016 brought a new beginning with Merck's opening of its new Exploratory Science Center in Cambridge, a cutting edge facility that will focus on early discovery research. The Cambridge ESC opened at the end of December and currently operates with a team of about 15 researchers.

    Jan 24, 2017

  • BMG LABTECH Announces Genedata Screener Integration

    Bio-IT World Brief | BMG LABTECH collaborates with Genedata to provide a functionally rich integration between BMG LABTCH’s entire product range of dedicated and multi-mode microplate readers and Genedata Screener, a data analysis and management platform for in-vitro screening technologies.

    Jan 20, 2017

  • Whole Genome Sequencing Testing Is Available At The New York Genome Center

    Bio-IT World | Whole genome sequencing testing, available at the New York Genome Center, brings precision medicine one step closer to reality. Researchers, physicians, and patients are finding new ways to use the information encoded in genes. 

    Jan 19, 2017

  • China Aims To Build World’s First Exascale Supercomputer Prototype By End Of 2017

    The Verge | Building supercomputers is a digital arms race, and China is moving quickly to solidify its lead. This year the government has set its sights on completing the world's first prototype exascale computer; a machine capable of making a billion calculations per second.

    Jan 19, 2017

  • Obama Administration Decides Consent Of Patients Not Needed To Study Their Blood DNA

    NPR.org | In its update of ethics rules aimed at protecting patients, the Obama administration decided against a provision that scientists said would hinder research. Consumer advocates aren't happy.

    Jan 18, 2017

  • AI Software Learns to Make AI Software

    MIT Technology Review | Google and others think software that learns to learn could take over some work done by AI experts.

    Jan 18, 2017

  • Where The Money Is: 2016 Edition

    ENDPOINTS NEWS | Thomson Reuters dug up investment numbers for all of the top 100 VCs investing in biotech, and Endpoints News ranked them. Flagship, Third Rock, New Enterprise Associates, and Arch Venture are the top four, and many of the top four players remain focused on early stage investment.

    Jan 18, 2017

  • Novogene Purchases 10 PacBio Sequel Systems

    Bio-IT World Brief | Novogene today announced its intention to purchase 10 Sequel Systems for whole genome sequencing, Iso-Seq annotation and targeted sequencing services from Pacific Biosciences.

    Jan 16, 2017

  • The Stem-Cell Revolution Is Coming — Slowly

    The New York Times | Where are the miracle treatments we were promised? A Nobel Prize-winning scientist explains.

    Jan 16, 2017

  • Biotech IPO Master Is Still Setting Up New Biotechs And Hatching More Deals

    ENDPOINTS NEWS | Vivek Ramaswamy blindsided the biotech industry with a record-setting IPO for the mystery biotech Axovant. The one-time hedge fund maestro turned drug entrepreneur has set up three more companies and taken one of them public at near supersonic speed, all while busily in-licensing drugs from a growing list of suppliers.

    Jan 13, 2017

  • JP Morgan News Round Up

    Bio-IT World Brief | The JP Morgan Healthcare Conference was held this week in San Francisco, kicking off 2017 with news and deals and product announcements. Many presentations were webcast. Here are some of the highlights and news bits we’ve collected over the past three days.

    Jan 12, 2017

  • Illumina Launches NovaSeq Sequencers, Aiming To Replace 1900 Sequencers

    Bio-IT World Speaking at the J.P. Morgan Healthcare Conference this afternoon, Francis deSouza, President and CEO of Illumina, unveiled the NovaSeq series, a new and scalable sequencing architecture, comprised of two instruments: the NovaSeq 5000 and NovaSeq 6000.

    Jan 9, 2017

  • Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline

    Forbes | What drugs is Moderna developing? It finally gives some details at JP Morgan.

    Jan 9, 2017

  • PatientsLikeMe Joins Wang's iCarbonX Digital Life Alliance Cornerstone

    Diagnostics World | Last week PatientsLikeMe announced a partnership and investment from iCarbonX that positions PatientsLikeMe as the cornerstone of Jun Wang's iCarbonX Digital Life Alliance, which aims to digitize and analyze all aspects of life.

    Jan 9, 2017

  • Will Our Government’s Multi-Billion-Dollar Investment In Genome Science Pay Off?

    Pacific Standard | Though the medical benefits of genome science have been marginal thus far, the government's multi-billion-dollar investment could pay off with the right policy adjustments.

    Jan 9, 2017

  • Interference: A CRISPR Patent Dispute Roadmap

    Bio-IT World | An epic CRISPR litigation battle between a host of universities has erupted involving CRISPR/Cas9, which can have major implications for the gene-editing technology community.

    Jan 9, 2017

  • Guide RNA Synthesis Firm Synthego Gets Investment, Vote Of Doudna Confidence

    Bio-IT World This week Synthego, a leading provider of genome engineering solutions, announced a $41 million Series B financing, bringing the company’s total fundraising to $50 million. The latest round includes investment from several venture firms, as well as direct, individual investments from Jennifer Doudna and Jamie Cate.

    Jan 6, 2017

  • BioTeam’s Berman Charts 2017 HPC Trends in Life Sciences

    HPCwire | Twenty years ago high performance computing was nearly absent from life sciences. Today it's used throughout life sciences and biomedical research. Genomics and the data deluge from modern lab instruments are the main drivers, but so is the longer-term desire to perform predictive simulation in support of Precision Medicine (PM).

    Jan 6, 2017